NOBL logo

NOBL
ProShares S&P 500 Dividend Aristocrats ETF

1,539
Volume
483,442.00
52W High
$110.01
52W Low
$89.76
50D MA
$104.49
Prev Close
$109.77
Loading...
Loading...
News
all
press releases
Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?
Smart Beta ETF report for NOBL
Zacks·2d ago
News Placeholder
More News
News Placeholder
ALB Stock Garners Retail Attention As Lithium Bulls Return
Albemarle Corp shares rose 2.6% in premarket trading on Tuesday, following a Deutsche Bank upgrade to ‘buy’ from ‘hold’.
Stocktwits·3d ago
News Placeholder
Take the Zacks Approach to Beat the Markets: Indivior, FIGS & Ulta Beauty in Focus
Zacks highlights how Indivior, FIGS and Ulta Beauty delivered outsized gains as its ranks, recommendations and focus lists beat a volatile market.
Zacks·4d ago
News Placeholder
Take the Zacks Approach to Beat the Markets: Castle Biosciences, Hamilton Insurance & Monster Beverage in Focus
Castle Biosciences surged 77.9% after a Zacks upgrade, highlighting how the firm's stock picks outpaced the broader market in recent months.
Zacks·18d ago
News Placeholder
Take the Zacks Approach to Beat the Markets: Liquidia, Western Digital & Johnson & Johnson in Focus
Liquidia shares have surged 43.9% since an October upgrade, as Zacks highlights stock wins and portfolio results despite a volatile market.
Zacks·1mo ago
News Placeholder
Take the Zacks Approach to Beat the Markets: MBX Biosciences, Garrett Motion & Monster Beverage in Focus
MBX Biosciences' sharp rally highlights how Zacks' stock recommendations outpaced broader market gains across multiple portfolios.
Zacks·2mo ago
News Placeholder
Take the Zacks Approach to Beat the Markets: Macy's, United Natural Foods & Monster Beverage in Focus
Macy's climbs after a Zacks upgrade as multiple portfolios showcase strong gains across UNFI, Monster Beverage and other standout stocks.
Zacks·2mo ago
News Placeholder
Buffett's Investing Lessons: What They Mean for ETF Investors
Buffett's final lessons guide ETF investors toward discipline, cash strength and quality picks like SPY, ITOT, VTV and MINT.
Zacks·2mo ago
News Placeholder
Beat the Market the Zacks Way: MariMed, Xeris Biopharma, Lam Research in Focus
MariMed, Xeris Biopharma and Lam Research shine as Zacks' proven stock strategies continue to beat the market despite turmoil.
Zacks·3mo ago
News Placeholder
Take the Zacks Approach to Beat the Markets: Amneal Pharmaceuticals, Leidos & Vishay Precision in Focus
Amneal Pharmaceuticals, Leidos and Vishay Precision stand out as Zacks highlights amid market volatility and shifting rate expectations.
Zacks·3mo ago
<
1
2
...
>

Latest NOBL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.